3SBio

Asia
Pharma

Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia

Kyowa Kirin ended its autoimmune program after new cancer reports. Sanofi linked up with Sino Biopharm. BioNTech advanced a DualityBio ADC. And more.
Angus Liu Mar 6, 2026 9:35am
newspaper

Pfizer, Akeso, Lilly and more—Fierce Pharma Asia

Nov 14, 2025 8:50am
Pfizer
Favicon Fierce Biotech

Pfizer lays out its PD-1xVEGF bispecific research strategy

Nov 11, 2025 11:43am
newspaper

Moderna, Otsuka-Lundbeck, Pfizer-3SBio—Fierce Pharma Asia

Jul 25, 2025 9:46am
Asia

Pfizer, Alzheimer's blood test, Samsung—Fierce Pharma Asia

May 23, 2025 9:00am
Asia Map

Sinopharm, Sinovac, Takeda and more—FiercePharmaAsia

Jun 19, 2020 10:44am